Skip to content

The efficacy of Ginger in reducing post operative nausea and vomiting in infertilized women after gynecologic laparoscopic surgery

The efficacy of Ginger in reducing post operative nausea and vomiting in infertilized women after gynecologic laparoscopic surgery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201110017681N1
Enrollment
100
Registered
2011-10-16
Start date
2011-02-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post operative nausea and vomiting. Nausea and vomiting

Interventions

Intervention 1: Group A: two capsules of placebo. Intervention 2: Group B: two capsules of Ginger (each capsule contained 250 milligram of powdered Ginger).
Placebo
Treatment - Drugs
Group A: two capsules of placebo
Group B: two capsules of Ginger (each capsule contained 250 milligram of powdered Ginger).

Sponsors

Anesthesia Research Center of Shahis Beheshti University Of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion: patients aged between 20 to 50 years who are satisfied in participating in the study and referred to Tehran Taleghani Hospital for gynecologic laparoscopic surgery. Exclusion: patients with ASA grade 3 and above; diabetic patients; smokers; patients with a history of gastriintestinal tract problems; consumers of calcium channel blocker drugs or anticoagulant drugs such as aspirin, warfarin, and ... ; Alcoholics.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Post operative vomiting. Timepoint: 0-2-6-24 hours after surgery. Method of measurement: frequency of vomiting.

Secondary

MeasureTime frame
Post operative nausea. Timepoint: 0-2-6-24 hours after surgery. Method of measurement: The intensity of nausea is measured with verbal 11-point numeric rating scale (NRS), with which the patient is asked to rate severity of nausea between 0 and 10, with 0 corresponding to no symptoms and 10 corresponding to worst possible symptoms.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHoda Amini Ranjbar

Tabriz University Of Medical Sciences

Aminiho@tbzmed.ac.ir+98 41 1335 5921

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026